India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Hepatitis: Why, how and who gets it? In colloquial language, hepatitis is also called 'jaundice'. Hepatitis is mostly caused by viruses. But sometimes it is also caused by bacteria or side effects of medicine. Hepatitis caused by viruses or bacteria can cause serious problems. Hepatitis is of two types, chronic and acute. The early stage of hepatitis is called acute, while the chronic problem is called chronic. The initial stage of hepatitis lasts for the first three months. If it is not treated even for six months, it takes the form of chronic hepatitis. If the body starts turning yellow with hepatitis in the initial stage, if it is not treated in the right way, it starts to take a chronic form. Even after that, if hepatitis is not treated properly, it will turn into cirrhosis of the liver, which will damage the entire liver. Liver cancer can also be caused by this. Generally, there are five types of hepatitis A, B, C, D and E. Among them, Hepatitis B is considered to be the m...